Homepage

Zhongchao Inc.

ZCMD NASDAQ Categories PDF
Healthcare · Medical - Healthcare Information Services
Shanghai, SH 200040, China IPO 2020 izcmd.com Updated Jun 26, 9:01am
Price
$0.36
Market Cap
$37,924
Employees
33
Beta
-0.15
Avg Volume
741,323
CEO
Weiguang Yang
Business Description

Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People’s Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, including the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.

Business History
Price Overview
Last updated: Jun 27, 2026 8:07am (just now)
$0.32
-0.05 (-12.75%)
Day Range
$0.30 – $0.61
52-Week Range
$0.30 – $322.65
50-Day MA
$33.92
200-Day MA
$111.71
Volume
41,961,413.00
Share Structure
Outstanding 104,186.00
Float 78,109.00
Free Float 75.0%
Normal free float — 75.0% of shares trade freely, ~25% held by insiders/institutions
Healthy float typical of established companies. Good liquidity for entering and exiting positions without major price impact.
Small absolute float (0.1M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Last updated: Jun 27, 2026 8:07am (just now)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 20, 2026 9:56am (6d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-0.01
Stock Price: $0.36
EPS (Diluted): -57.35
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
0.66
Stock Price: $0.36
Total Equity: $18.63M
Shares: 110,267
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
1.48
Market Cap: $37,924
Total Debt: $0.00
Cash: $8.10M
EBITDA: -$5.45M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$4.2M
Market Cap: $37,924
Total Debt: $0.00
Cash: $8.10M
P/S Ratio (Price per dollar of revenue)
API
Stock Price / Revenue Per Share
1.08
Stock Price: $0.36
Revenue: $11.37M
Shares: 110,267
EV/Sales (Total value vs revenue — works when P/E can't)
API
0.37
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
42.5%
Gross Profit: $4.83M
Revenue: $11.37M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-54.4%
Operating Income: -$6.19M
Revenue: $11.37M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-55.5%
Net Income: -$6.31M
Revenue: $11.37M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-32.4%
Net Income: -$6.31M
Total Equity: $18.63M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-27.1%
Operating Income: -$6.19M
Tax Rate: -0.8%
Equity: $18.63M
Total Debt: $0.00
Cash: $8.10M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
11.11
Current Assets: $16.96M
Current Liabilities: $1.53M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $18.63M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$103.16
Revenue: $11.37M
Shares: 110,267
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$168.96
Total Equity: $18.63M
Shares: 110,267
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$6.28
Operating CF: $845,391
CapEx: -$152,561
Shares: 110,267
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.36
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: -$6.31M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares ZCMD against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 20, 2026 9:56am (6d ago)
Metric 2021 2022 2023 2024 2025
Revenue $16.3M $14.2M $19.4M $15.9M $11.4M
Cost of Revenue $6.9M $7.8M $10.9M $7.0M $6.5M
Gross Profit $9.4M $6.4M $8.5M $8.9M $4.8M
Operating Expenses $9.8M $9.3M $21.8M $9.3M $11.0M
Operating Income $-320,741 -$3.0M -$13.3M $-341,267 -$6.2M
Net Income $238,665 -$2.9M -$11.3M $-643,229 -$6.3M
EBITDA $592,224 -$1.8M -$4.5M $87,951 -$5.4M
EPS $23.81 $-280.24 $-1,078.80 $-29.76 $-57.35
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 20, 2026 9:56am (6d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $13.9M $11.5M $7.5M $7.8M $8.1M
Total Current Assets $27.3M $22.7M $18.7M $18.7M $17.0M
Total Assets $36.3M $38.6M $24.4M $25.9M $24.3M
Current Liabilities $3.6M $4.2M $2.7M $1.5M $1.5M
Long-Term Debt $0 $0 $0 $0 $0
Total Liabilities $3.7M $5.6M $3.4M $1.7M $1.7M
Total Equity $32.6M $29.9M $18.0M $20.8M $18.6M
Retained Earnings $7.2M $4.1M -$7.3M -$8.0M -$14.2M
Cash Flow (Annual)
Last updated: Jun 20, 2026 9:56am (6d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $2.9M $-661,740 $54,229 -$1.5M $845,391
Capital Expenditure -$1.8M -$1.9M $-839,736 -$3.0M $-152,561
Free Cash Flow $1.1M -$2.5M $-785,507 -$4.5M $692,830
Acquisitions (net) $-708,129 -$3.0M $0 $0 $0
Debt Repayment
Dividends Paid
Stock Buybacks $0 $0 $0 $0 $0
Net Change in Cash -$1.2M -$2.4M -$4.0M $292,612 $256,769
Growth Trends (YoY %)
Last updated: Jun 20, 2026 9:56am (6d ago)
Metric 2022 2023 2024 2025
Revenue Growth -13.2% +37.3% -18.4% -28.3%
Gross Profit Growth -32.7% +33.9% +4.7% -45.8%
Operating Income Growth -821.1% -349.6% +97.4% -1,714.2%
Net Income Growth -1,332.2% -285.5% +94.3% -881.0%
EBITDA Growth -407.3% -146.6% +102.0% -6,293.2%
Insider Trading (Recent)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-03-18 Vassily Kevin 0.00 $0.00 $0
2026-03-18 General John Conrad 0.00 $0.00 $0
2026-03-18 Xu Pei 0.00 $0.00 $0
2026-03-18 LI DAN 0.00 $0.00 $0
2026-03-18 Yang Weiguang 0.00 $0.00 $0
2026-03-18 Yang Weiguang 0.00 $0.00 $0
2026-03-18 Yang Weiguang 0.00 $0.00 $0
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for ZCMD — it's generated by the pipeline (market-narrative step).
Community AI Feedback
No community reviews yet for ZCMD. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30